ProShare Advisors’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.2K | Sell |
11,146
-2,297
| -17% | -$7.88K | ﹤0.01% | 2024 |
|
|
2025
Q1 | $30K | Sell |
13,443
-547
| -4% | -$1.22K | ﹤0.01% | 2002 |
|
|
2024
Q4 | $41K | Sell |
13,990
-3,422
| -20% | -$10K | ﹤0.01% | 2204 |
|
|
2024
Q3 | $45.3K | Sell |
17,412
-740
| -4% | -$1.92K | ﹤0.01% | 1987 |
|
|
2024
Q2 | $53.7K | Sell |
18,152
-2,366
| -12% | -$7K | ﹤0.01% | 1742 |
|
|
2024
Q1 | $92.9K | Buy |
20,518
+1,978
| +11% | +$8.96K | ﹤0.01% | 1834 |
|
|
2023
Q4 | $106K | Sell |
18,540
-376
| -2% | -$2.15K | ﹤0.01% | 1774 |
|
|
2023
Q3 | $87K | Buy |
18,916
+234
| +1% | +$1.08K | ﹤0.01% | 1656 |
|
|
2023
Q2 | $121K | Sell |
18,682
-25,638
| -58% | -$166K | ﹤0.01% | 1666 |
|
|
2023
Q1 | $334K | Sell |
44,320
-5,989
| -12% | -$45.2K | ﹤0.01% | 1146 |
|
|
2022
Q4 | $510K | Buy |
50,309
+3,495
| +7% | +$35.4K | ﹤0.01% | 953 |
|
|
2022
Q3 | $463K | Buy |
46,814
+1,391
| +3% | +$13.8K | ﹤0.01% | 927 |
|
|
2022
Q2 | $484K | Buy |
45,423
+15,940
| +54% | +$170K | ﹤0.01% | 948 |
|
|
2022
Q1 | $287K | Sell |
29,483
-10,170
| -26% | -$99K | ﹤0.01% | 1654 |
|
|
2021
Q4 | $567K | Buy |
+39,653
| New | +$567K | ﹤0.01% | 1358 |
|